3-(4-bromo-1H-pyrazol-1-yl)propanenitrile, 95.0%, 2g

2-(5-Bromo-2-methyl-2H-indazol-3-yl)propan-2-ol, 98%, 250mg

4-thien-2-yl-1,3-thiazol-2(3H)-one, 1g

Indium(III) oxide, 99.0%, 5g

4-Nitrophenyl beta-D-Glucuronide [Substrate for beta-Glucuronidase]>98.0%(HPLC)100mg

2-(butyrylamino)-4-chlorobenzoic acid, 95.0%, 1g

(R)-N-(4-(3-AMINOPIPERIDIN-1-YL)-5-BROMO-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)CYCLOPROPANECARBOXAMIDE, 95%, 25mg

3-Morpholin-4-yl-propionic acid hydrochloride, 95.0%, 5g

6-Bromo-2-fluoro-3-hydroxybenzaldehyde, 97%, 5g

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95%, 1g

1,5-Dimethyl-1H-pyrazol-4-ylamine dihydrochloride, 95.0%, 250mg

5H-Pyrrolo[1,2-a]imidazol-7(6H)-one, 95+%, 100mg

1-Phenylcyclobutanecarbonitrile, 97.0%, 1g